<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Primary Care Health Sciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BD1713FC-53AF-4EB9-AEA9-E553B9B828C8"><gtr:id>BD1713FC-53AF-4EB9-AEA9-E553B9B828C8</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Glasziou</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F4E5802F-0D36-4949-98EF-EADC9B2E0261"><gtr:id>F4E5802F-0D36-4949-98EF-EADC9B2E0261</gtr:id><gtr:firstName>Rafael</gtr:firstName><gtr:surname>Perera</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/911BC1CA-D95E-4FC2-A935-EC36E5C4DE54"><gtr:id>911BC1CA-D95E-4FC2-A935-EC36E5C4DE54</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Walter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E10DE2C5-C4A1-470C-AF5C-7E9FB2B86AD1"><gtr:id>E10DE2C5-C4A1-470C-AF5C-7E9FB2B86AD1</gtr:id><gtr:firstName>Gordon</gtr:firstName><gtr:surname>Guyatt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F240553F-C36E-4CB5-BE45-40A26C5E5BFD"><gtr:id>F240553F-C36E-4CB5-BE45-40A26C5E5BFD</gtr:id><gtr:firstName>Dirk</gtr:firstName><gtr:surname>Bassler</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600561"><gtr:id>AD0205C4-73BF-4CE6-A6B0-DFCB5A4EC358</gtr:id><gtr:title>Study Of Trial Policy Of Interim Trucation-2 (STOP-IT-2)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600561</gtr:grantReference><gtr:abstractText>A recent review 143 randomized trials that stopped earlier than 
planned because of a larger than expected treatment effect showed 
that such trials are increasingly common but often show implausibly 
large treatment effects. This study (STOP IT-2) aims to understand 
how biased such early stopping is, and how we might fix the problem. 
To do this we will find and summarise all other research trials that 
answer the same questions as those that stopped early and compare the 
results. The results will have considerable importance to the 
interpretation of trials that stop early, and will help clinicians, 
policy makers and consumers in interpreting such trials.</gtr:abstractText><gtr:technicalSummary>Recently, Montori et al. published STOPIT-1 , a systematic review 
(SR) of 143 randomized trials that stopped earlier than planned 
because of a larger than expected treatment effect (JAMA 
2005;294:2203-2209). Such truncated randomised trials (tRCT) are 
becoming increasingly common but often show implausibly large 
treatment effects. STOP IT-2 seeks to determine the magnitude and 
determinants of bias that truncation introduces. We will search for 
SRs addressing the same question as the 143 tRCTs in STOPIT-1. For 
each of the SRs we will conduct meta-analyses addressing the outcome 
that led to the early termination of the tRCT(s) and compare the 
relative risk (RR) generated by the tRCT with the RR from all other 
studies. Second we will use multivariable regression to determine the 
independent contribution of the decision to stop early on the 
magnitude of the treatment effect and modifiers of that contribution 
(such as, for instance, the number of events that had occurred at the 
time of truncation). Finally, we will compare possible methods for 
debiasing the estimates from tRCTs, in particular the use of Bayesian 
methods using conservative informative priors to regress to the 
mean overoptimistic small studies.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>222366</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>901A15C0-6902-4903-826E-65C65D7C3928</gtr:id><gtr:title>Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36eef1ee2bd1de5a302cb165240ef2ba"><gtr:id>36eef1ee2bd1de5a302cb165240ef2ba</gtr:id><gtr:otherNames>Bassler D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>ScS3Q1UbRWQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65FE03B1-CAAC-49C5-AA4A-217C581F9CA9</gtr:id><gtr:title>Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6ae8bc3c6e6175578fd2854bc90126"><gtr:id>ad6ae8bc3c6e6175578fd2854bc90126</gtr:id><gtr:otherNames>Briel M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>B70BE9D7412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>569C8527-4A61-4BE1-A27C-EE8A90D2FBA1</gtr:id><gtr:title>Early stopping of randomized clinical trials for overt efficacy is problematic.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36eef1ee2bd1de5a302cb165240ef2ba"><gtr:id>36eef1ee2bd1de5a302cb165240ef2ba</gtr:id><gtr:otherNames>Bassler D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>1E1978BDA0D</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600561</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>90487A08-C473-4CEB-B6D9-011A74AD06CF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>8.4  Research design and methodologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>